Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: They want the publics opinion,

FYI.. You can not call to submit your opinion... as just explained to me by Megan.. you must electronically file a written document and submit 8 hard copies in order to make it official... as explained in the following text (continuing toxic waste's original post) scroll down..

Megan M. Valentine, Office of the

General Counsel, U.S. International

Trade Commission, 500 E Street SW.,

Washington, DC 20436, telephone (202)

708–2301. The public version of the

complaint can be accessed on the

Commission’s electronic docket (EDIS

at http://edis.usitc.gov, and will be

available for inspection during official

business hours (8:45 a.m. to 5:15 p.m.)

in the Office of the Secretary, U.S.

International Trade Commission, 500 E

Street SW., Washington, DC 20436,

telephone (202) 205–2000.

General information concerning the

Commission may also be obtained by

accessing its Internet server (http://

www.usitc.gov). The public record for

this investigation may be viewed on the

Commission’s electronic docket (EDIS)

at http://edis.usitc.gov. Hearing-

impaired persons are advised that

information on this matter can be

obtained by contacting the

Commission’s TDD terminal on (202)

205–1810.

SUPPLEMENTARY INFORMATION: Section

337 of the Tariff Act of 1930 provides

that if the Commission finds a violation

it shall exclude the articles concerned

from the United States:

unless, after considering the effect of such

exclusion upon the public health and

welfare, competitive conditions in the United

States economy, the production of like or

directly competitive articles in the United

States, and United States consumers, it finds

that such articles should not be excluded

from entry.

19 U.S.C. 1337(d)(1). A similar

provision applies to cease and desist

orders. 19 U.S.C. 1337(f)(1).

The Commission is interested in

further development of the record on

the public interest in these

investigations. Accordingly, members of

the public are invited to file

submissions of no more than five (5)

pages, inclusive of attachments,

concerning the public interest in light of

the administrative law judge’s

Recommended Determination on

Remedy and Bonding issued in this

investigation on September 6, 2013.

Comments should address whether

issuance of a limited exclusion order

and cease and desist orders in this

investigation would affect the public

health and welfare in the United States,

competitive conditions in the United

States economy, the production of like

or directly competitive articles in the

United States, or United States

consumers.

In particular, the Commission is

interested in comments that:

(i) explain how the articles potentially

subject to the recommended orders are

used in the United States;

(ii) identify any public health, safety,

or welfare concerns in the United States

relating to the recommended orders;

(iii) identify like or directly

competitive articles that complainant,

its licensees, or third parties make in the

United States which could replace the

subject articles if they were to be

excluded;

(iv) indicate whether complainant,

complainant’s licensees, and/or third

party suppliers have the capacity to

replace the volume of articles

potentially subject to the recommended

exclusion order and/or a cease and

desist order within a commercially

reasonable time; and

(v) explain how the limited exclusion

order and cease and desist orders would

impact consumers in the United States.

Written submissions must be filed no

later than by close of business on

October 7, 2013.

Persons filing written submissions

must file the original document

electronically on or before the deadlines

stated above and submit 8 true paper

copies to the Office of the Secretary by

noon the next day pursuant to section

210.4(f) of the Commission’s Rules of

Practice and Procedure (19 CFR

210.4(f)). Submissions should refer to

the investigation number (‘‘Inv. No.

337–TA–853’’) in a prominent place on

the cover page and/or the first page. (See

Handbook for Electronic Filing

Procedures, http://www.usitc.gov/

secretary/fed_reg_notices/rules/

handbook_on_electronic_ filing.pdf).

Persons with questions regarding filing

should contact the Secretary (202–205–

2000).

Any person desiring to submit a

document to the Commission in

confidence must request confidential

treatment. All such requests should be

directed to the Secretary to the

Commission and must include a full

statement of the reasons why the

Commission should grant such

treatment. See 19 CFR 201.6. Documents

for which confidential treatment by the

Commission is properly sought will be

treated accordingly. A redacted non-

confidential version of the document

must also be filed simultaneously with

the any confidential filing. All non-

confidential written submissions will be

available for public inspection at the

Office of the Secretary and on EDIS.

This action is taken under the

authority of section 337 of the Tariff Act

of 1930, as amended (19 U.S.C. 1337),

and of sections 201.10 and 210.50 of the

Commission’s Rules of Practice and

Procedure (19 CFR 201.10, 210.50).

Issued: September 9, 2013.

By order of the Commission.

Lisa R. Barton,

Acting Secretary to the Commission.

[FR Doc. 2013–22189 Filed 9–11–13; 8:45 am]

BILLING CODE 7020–02–P

-------------------------------

The 8 hard copies are mailed to:

United States International Trade Commission

*Office of Secretary*

500 E Street SW

Washington DC 20436

Share
New Message
Please login to post a reply